JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: However, when facing a change in the clinical course of either CML or Ph-negative MPN, hematologists and pathologists need to exclude even the possibility of a combination of BCR::ABL1 translocation and JAK2 mutation.